Global Drugs for Vaginal Fungal Infections market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Drugs for Vaginal Fungal Infections Market Size, Share and Analysis

The global Drugs for Vaginal Fungal Infections market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Drugs for Vaginal Fungal Infections Industry Forecast looks at past sales and reviews total world Drugs for Vaginal Fungal Infections sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Vaginal Fungal Infections sales for 2025 through 2031. With Drugs for Vaginal Fungal Infections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Vaginal Fungal Infections industry. This Insight Report provides a comprehensive analysis of the global Drugs for Vaginal Fungal Infections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs for Vaginal Fungal Infections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Drugs for Vaginal Fungal Infections market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Vaginal Fungal Infections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Vaginal Fungal Infections. This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Vaginal Fungal Infections market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Fluconazole &nbsp;&nbsp;&nbsp; Nystatin &nbsp;&nbsp;&nbsp; Flucytosine &nbsp;&nbsp;&nbsp; Clotrimazole &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; Bausch Health Companies Inc &nbsp;&nbsp;&nbsp; ANl Pharmaceuticals, Inc &nbsp;&nbsp;&nbsp; Hikma Pharmaceuticals Plc &nbsp;&nbsp;&nbsp; Lupin Limited &nbsp;&nbsp;&nbsp; Mycovia Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Glenmark Pharmaceuticals Limited &nbsp;&nbsp;&nbsp; Unique Pharmaceuticals &nbsp;&nbsp;&nbsp; PEPTONIC Medical AB &nbsp;&nbsp;&nbsp; Aurobindo Pharma Limited &nbsp;&nbsp;&nbsp; Dr. Reddys Laboratories &nbsp;&nbsp;&nbsp; SCYNEXIS,Inc. &nbsp;&nbsp;&nbsp; Basilea Pharmaceutica Ltd. &nbsp;&nbsp;&nbsp; Astellas Pharma lnc. &nbsp;&nbsp;&nbsp; Grupo Ferrer Internacional,S.A. &nbsp;&nbsp;&nbsp; Pacgen Life Science Corporation &nbsp;&nbsp;&nbsp; NovaDigm Therapeutics, Inc. &nbsp;&nbsp;&nbsp; Cidara Therapeutics, Inc. &nbsp;&nbsp;&nbsp; Amplyx Pharmaceuticals Inc.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Drugs for Vaginal Fungal Infections Market Size (2020-2031) &nbsp;2.1.2 Drugs for Vaginal Fungal Infections Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Drugs for Vaginal Fungal Infections by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Drugs for Vaginal Fungal Infections Segment by Type &nbsp;2.2.1 Fluconazole &nbsp;2.2.2 Nystatin &nbsp;2.2.3 Flucytosine &nbsp;2.2.4 Clotrimazole &nbsp;2.2.5 Others &nbsp;2.3 Drugs for Vaginal Fungal Infections Market Size by Type &nbsp;2.3.1 Drugs for Vaginal Fungal Infections Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Drugs for Vaginal Fungal Infections Market Size Market Share by Type (2020-2025) &nbsp;2.4 Drugs for Vaginal Fungal Infections Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Others &nbsp;2.5 Drugs for Vaginal Fungal Infections Market Size by Application &nbsp;2.5.1 Drugs for Vaginal Fungal Infections Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Drugs for Vaginal Fungal Infections Market Size Market Share by Application (2020-2025) 3 Drugs for Vaginal Fungal Infections Market Size by Player &nbsp;3.1 Drugs for Vaginal Fungal Infections Market Size Market Share by Player &nbsp;3.1.1 Global Drugs for Vaginal Fungal Infections Revenue by Player (2020-2025) &nbsp;3.1.2 Global Drugs for Vaginal Fungal Infections Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Drugs for Vaginal Fungal Infections Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Drugs for Vaginal Fungal Infections by Region &nbsp;4.1 Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) &nbsp;4.2 Global Drugs for Vaginal Fungal Infections Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Drugs for Vaginal Fungal Infections Market Size Growth (2020-2025) &nbsp;4.4 APAC Drugs for Vaginal Fungal Infections Market Size Growth (2020-2025) &nbsp;4.5 Europe Drugs for Vaginal Fungal Infections Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) &nbsp;5.2 Americas Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) &nbsp;5.3 Americas Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) &nbsp;6.2 APAC Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) &nbsp;6.3 APAC Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) &nbsp;7.2 Europe Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) &nbsp;7.3 Europe Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Drugs for Vaginal Fungal Infections by Region (2020-2025) &nbsp;8.2 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Drugs for Vaginal Fungal Infections Market Forecast &nbsp;10.1 Global Drugs for Vaginal Fungal Infections Forecast by Region (2026-2031) &nbsp;10.1.1 Global Drugs for Vaginal Fungal Infections Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Drugs for Vaginal Fungal Infections Forecast &nbsp;10.1.3 APAC Drugs for Vaginal Fungal Infections Forecast &nbsp;10.1.4 Europe Drugs for Vaginal Fungal Infections Forecast &nbsp;10.1.5 Middle East & Africa Drugs for Vaginal Fungal Infections Forecast &nbsp;10.2 Americas Drugs for Vaginal Fungal Infections Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.2.2 Canada Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.2.3 Mexico Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.2.4 Brazil Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.3 APAC Drugs for Vaginal Fungal Infections Forecast by Region (2026-2031) &nbsp;10.3.1 China Drugs for Vaginal Fungal Infections Market Forecast &nbsp;10.3.2 Japan Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.3.3 Korea Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.3.4 Southeast Asia Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.3.5 India Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.3.6 Australia Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.4 Europe Drugs for Vaginal Fungal Infections Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.4.2 France Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.4.3 UK Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.4.4 Italy Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.4.5 Russia Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.5 Middle East & Africa Drugs for Vaginal Fungal Infections Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.5.2 South Africa Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.5.3 Israel Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.5.4 Turkey Market Drugs for Vaginal Fungal Infections Forecast &nbsp;10.6 Global Drugs for Vaginal Fungal Infections Forecast by Type (2026-2031) &nbsp;10.7 Global Drugs for Vaginal Fungal Infections Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Drugs for Vaginal Fungal Infections Forecast 11 Key Players Analysis &nbsp;11.1 Pfizer Inc. &nbsp;11.1.1 Pfizer Inc. Company Information &nbsp;11.1.2 Pfizer Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.1.3 Pfizer Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Pfizer Inc. Main Business Overview &nbsp;11.1.5 Pfizer Inc. Latest Developments &nbsp;11.2 Bausch Health Companies Inc &nbsp;11.2.1 Bausch Health Companies Inc Company Information &nbsp;11.2.2 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.2.3 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Bausch Health Companies Inc Main Business Overview &nbsp;11.2.5 Bausch Health Companies Inc Latest Developments &nbsp;11.3 ANl Pharmaceuticals, Inc &nbsp;11.3.1 ANl Pharmaceuticals, Inc Company Information &nbsp;11.3.2 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.3.3 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 ANl Pharmaceuticals, Inc Main Business Overview &nbsp;11.3.5 ANl Pharmaceuticals, Inc Latest Developments &nbsp;11.4 Hikma Pharmaceuticals Plc &nbsp;11.4.1 Hikma Pharmaceuticals Plc Company Information &nbsp;11.4.2 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.4.3 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Hikma Pharmaceuticals Plc Main Business Overview &nbsp;11.4.5 Hikma Pharmaceuticals Plc Latest Developments &nbsp;11.5 Lupin Limited &nbsp;11.5.1 Lupin Limited Company Information &nbsp;11.5.2 Lupin Limited Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.5.3 Lupin Limited Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Lupin Limited Main Business Overview &nbsp;11.5.5 Lupin Limited Latest Developments &nbsp;11.6 Mycovia Pharmaceuticals, Inc. &nbsp;11.6.1 Mycovia Pharmaceuticals, Inc. Company Information &nbsp;11.6.2 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.6.3 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Mycovia Pharmaceuticals, Inc. Main Business Overview &nbsp;11.6.5 Mycovia Pharmaceuticals, Inc. Latest Developments &nbsp;11.7 Glenmark Pharmaceuticals Limited &nbsp;11.7.1 Glenmark Pharmaceuticals Limited Company Information &nbsp;11.7.2 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.7.3 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Glenmark Pharmaceuticals Limited Main Business Overview &nbsp;11.7.5 Glenmark Pharmaceuticals Limited Latest Developments &nbsp;11.8 Unique Pharmaceuticals &nbsp;11.8.1 Unique Pharmaceuticals Company Information &nbsp;11.8.2 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.8.3 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Unique Pharmaceuticals Main Business Overview &nbsp;11.8.5 Unique Pharmaceuticals Latest Developments &nbsp;11.9 PEPTONIC Medical AB &nbsp;11.9.1 PEPTONIC Medical AB Company Information &nbsp;11.9.2 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.9.3 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 PEPTONIC Medical AB Main Business Overview &nbsp;11.9.5 PEPTONIC Medical AB Latest Developments &nbsp;11.10 Aurobindo Pharma Limited &nbsp;11.10.1 Aurobindo Pharma Limited Company Information &nbsp;11.10.2 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.10.3 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Aurobindo Pharma Limited Main Business Overview &nbsp;11.10.5 Aurobindo Pharma Limited Latest Developments &nbsp;11.11 Dr. Reddy's Laboratories &nbsp;11.11.1 Dr. Reddy's Laboratories Company Information &nbsp;11.11.2 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.11.3 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Dr. Reddy's Laboratories Main Business Overview &nbsp;11.11.5 Dr. Reddy's Laboratories Latest Developments &nbsp;11.12 SCYNEXIS,Inc. &nbsp;11.12.1 SCYNEXIS,Inc. Company Information &nbsp;11.12.2 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.12.3 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 SCYNEXIS,Inc. Main Business Overview &nbsp;11.12.5 SCYNEXIS,Inc. Latest Developments &nbsp;11.13 Basilea Pharmaceutica Ltd. &nbsp;11.13.1 Basilea Pharmaceutica Ltd. Company Information &nbsp;11.13.2 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.13.3 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Basilea Pharmaceutica Ltd. Main Business Overview &nbsp;11.13.5 Basilea Pharmaceutica Ltd. Latest Developments &nbsp;11.14 Astellas Pharma lnc. &nbsp;11.14.1 Astellas Pharma lnc. Company Information &nbsp;11.14.2 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.14.3 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Astellas Pharma lnc. Main Business Overview &nbsp;11.14.5 Astellas Pharma lnc. Latest Developments &nbsp;11.15 Grupo Ferrer Internacional,S.A. &nbsp;11.15.1 Grupo Ferrer Internacional,S.A. Company Information &nbsp;11.15.2 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.15.3 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Grupo Ferrer Internacional,S.A. Main Business Overview &nbsp;11.15.5 Grupo Ferrer Internacional,S.A. Latest Developments &nbsp;11.16 Pacgen Life Science Corporation &nbsp;11.16.1 Pacgen Life Science Corporation Company Information &nbsp;11.16.2 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.16.3 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Pacgen Life Science Corporation Main Business Overview &nbsp;11.16.5 Pacgen Life Science Corporation Latest Developments &nbsp;11.17 NovaDigm Therapeutics, Inc. &nbsp;11.17.1 NovaDigm Therapeutics, Inc. Company Information &nbsp;11.17.2 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.17.3 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 NovaDigm Therapeutics, Inc. Main Business Overview &nbsp;11.17.5 NovaDigm Therapeutics, Inc. Latest Developments &nbsp;11.18 Cidara Therapeutics, Inc. &nbsp;11.18.1 Cidara Therapeutics, Inc. Company Information &nbsp;11.18.2 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.18.3 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Cidara Therapeutics, Inc. Main Business Overview &nbsp;11.18.5 Cidara Therapeutics, Inc. Latest Developments &nbsp;11.19 Amplyx Pharmaceuticals Inc. &nbsp;11.19.1 Amplyx Pharmaceuticals Inc. Company Information &nbsp;11.19.2 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Product Offered &nbsp;11.19.3 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 Amplyx Pharmaceuticals Inc. Main Business Overview &nbsp;11.19.5 Amplyx Pharmaceuticals Inc. Latest Developments 12 Research Findings and Conclusion

Report	Global Drugs for Vaginal Fungal Infections Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50800

Buyer Information

Order Summary